Pyridostigmine as Immunomodulator in People Living With HIV

Clinical trial NCT03312244 · SUSPENDED

Trial details

NCT number: NCT03312244
Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1-infection CD4+ T Lymphocytopenia Immune Deficiency Immuno-senescence

Start date: 2019-07-01
Primary completion: 2021-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.